BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Differential Effects of Anti-IL-1R Accessory Protein Antibodies on IL-1α or IL-1β-induced Production of PGE2 and IL-6 from 3T3-L1 Cells

  • Yoon, Do-Young (Laboratory of Cell and Immunobiochemistry, Department of Bioscience and Biotechnology, Konkuk University) ;
  • Dinarello, Charles A. (Department of Medicine, Division of Infectious Diseases, Univ. Colorado Health Sciences Center)
  • Published : 2007.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Soluble or cell-bound IL-1 receptor accessory protein (IL-1RAcP) does not bind IL-1 but rather forms a complex with IL-1 and IL-1 receptor type I (IL-1RI) resulting in signal transduction. Synthetic peptides to various regions in the Ig-like domains of IL-1RAcP were used to produce antibodies and these antibodies were affinity-purified using the respective antigens. An anti-peptide-4 antibody which targets domain III inhibited 70% of IL-$1\beta$-induced productions of IL-6 and PGE2 from 3T3-L1 cells. Anti-peptide-2 or 3 also inhibited IL-1-induced IL-6 production by 30%. However, antipeptide-1 which is directed against domain I had no effect. The antibody was more effective against IL-$1\beta$ compared to IL-$1\alpha$. IL-1-induced IL-6 production was augmented by coincubation with PGE2. The COX inhibitor ibuprofen blocked IL-1-induced IL-6 and PGE2 production. These results confirm that IL-1RAcP is essential for IL-1 signaling and that increased production of IL-6 by IL-1 needs the co-induction of PGE2. However, the effect of PGE2 is independent of expressions of IL-1RI and IL-1RAcP. Our data suggest that domain III of IL-1RAcP may be involved in the formation or stabilization of the IL-1RI/IL-1 complex by binding to epitopes on domain III of the IL-1RI created following IL-1 binding to the IL-1RI.

Keywords

References

  1. Akahoshi, T., Oppenheim, J. J. and Matsushima, K. (1988) Interleukin 1 stimulates its own receptor expression on human fibroblasts through the endogenous production of prostaglandin(s). J. Clin. Invest. 82, 1219-1224. https://doi.org/10.1172/JCI113719
  2. Araki, M., Yano, T., Hayashi, H., Takii, T., Suzuki, K. and Onozaki, K. (1994) Resistance to the anti-proliferative effect of IL-1 on human melanoma cell line is associated with endogenous production of IL-1 and IL-6. Int. J. Cancer 56, 275-280. https://doi.org/10.1002/ijc.2910560222
  3. Balavoine, J. F., de Rochemonteix, B., Williamson, K., Seckinger, P., Cruchaud, A. and Dayer, J-M. (1986) Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s). J. Clin. Invest. 78, 1120-1124. https://doi.org/10.1172/JCI112669
  4. Banda, N. K., Guthridge, C., Sheppard, D., Cairns, K. S., Muggli, M., Bech-Otschir, D., Dubiel, W. and Arend W. P. (2005) Intracellular IL-1 receptor antagonist type 1 inhibits IL-1-induced cytokine production in keratinocytes through binding to the third component of the COP9 signalosome. J. Immunol. 174, 3608-3616. https://doi.org/10.4049/jimmunol.174.6.3608
  5. Blechman, J. M., Lev, S., Barg, J., Eisenstein, M., Vaks, B., Vogel, Z., Givol, D. and Yarden, Y. (1995) The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell 80, 103-113. https://doi.org/10.1016/0092-8674(95)90455-7
  6. Boch, J. A., Yoshida, Y., Koyama, Y., Wara-Aswapati, N., Peng, H., Unlu, S. and Auron, P. E. (2003) Characterization of a cascade of protein interactions initiated at the IL-1 receptor. Biochem. Biophys. Res. Commun. 303, 525-531. https://doi.org/10.1016/S0006-291X(03)00385-1
  7. Buryskova, M., Pospisek, M., Grothey, A., Simmet, T. and Burysek, L. (2004) Intracellular interleukin-1alpha functionally interacts with histone acetyltransferase complexes. J. Biol. Chem. 279, 4017-4026. https://doi.org/10.1074/jbc.M306342200
  8. Cao, C., Matsumura, K., Yamagata, K. and Watanabe, Y. (1996) Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: a possible site of prostaglandin synthesis responsible for fever. Brain Res. 733, 263-272. https://doi.org/10.1016/0006-8993(96)00575-6
  9. Cao, H. J., Han, R. and Smith, T. J. (2003) Robust induction of PGHS-2 by IL-1 in orbital fibroblasts results from low levels of IL-1 receptor antagonist expression. Am. J. Physiol. Cell Physiol. 284, 1429-1437. https://doi.org/10.1152/ajpcell.00354.2002
  10. Chernoff, A. E., Granowitz, E. V., Shapiro, L., Vannier, E., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Wolff, S. M. and Dinarello, C. A. (1995) A randomized, controlled trial of interleukin-10 in humans: inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154, 5492-5499.
  11. Chou, P. Y. and Fasman, G. D. (1974) Prediction of protein conformation. Biochemistry 13, 222-245. https://doi.org/10.1021/bi00699a002
  12. Croston, G, E., Cao, Z. and Goeddel, D. V. (1995) NF-$\kappa$B activation by interleukin-1 requires an IL-1 receptor-associated protein kinase activity. J. Biol. Chem. 270, 16514-16517. https://doi.org/10.1074/jbc.270.28.16514
  13. Dinarello, C. A. (1996) Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147.
  14. Freshney, N. W., Rawlinson, L., Guesdon, F., Jones, E., Cowley, S., Hsuan, J. and Saklatvala, J. (1994) Interleukin-1 activates a novel protein cascade that results in the phosphorylation of hsp27. Cell 78, 1039-1049. https://doi.org/10.1016/0092-8674(94)90278-X
  15. Fukushima, H., Jimi, E., Okamoto, F., Motokawa, W. and Okabe, K. (2005) IL-1-induced receptor activator of NF-kappaB ligand in human periodontal ligament cells involves ERK-dependent PGE2 production. Bone 36, 267-275. https://doi.org/10.1016/j.bone.2004.09.011
  16. Greenfeder, S. A., Nunes, P., Kwee, L., Labow, M., Chizzonite, R. A. and Ju, G. (1995a) Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J Biol Chem. 270, 13757-13765. https://doi.org/10.1074/jbc.270.23.13757
  17. Greenfeder, S. A., Varnell, T., Powers, G., Lombard-Gillooly, K., Shuster, D., McIntyre, K. W., Ryan, D. E., Leven, W., Madison, V. and Ju, G. (1995b) Insertion of a structural domain of interleukin-1b confers agonist activity to the IL-1 receptor antagonist. J Biol. Chem. 270, 22460-22465. https://doi.org/10.1074/jbc.270.38.22460
  18. Guan, Z., Baier, L. D. and Morrison, A. R. (1997) p38 mitogenactivated protein kinase down-regulates nitric oxide and upregulates prostaglandin E2 biosynthesis stimulated by interleukin-1b. J. Biol. Chem. 272, 8083-8089. https://doi.org/10.1074/jbc.272.12.8083
  19. Heldin, C. H. and Ostman, A. (1996) Ligand-induced dimerization of growth factor receptors: Variations on the theme. Cytokine Growth Factor Rev. 7, 3-10. https://doi.org/10.1016/1359-6101(96)00002-0
  20. Kagiwada, K., Chida, D., Sakatani, T., Asano, M., Nambu, A., Kakuta, S. and Iwakura, Y. (2004) IL-6, but not IL-1, induction in the brain downstream of cyclooxygenase-2 is essential for the induction of febrile response against peripheral IL-1alpha. Endocrinology 145, 5044-5048. https://doi.org/10.1210/en.2004-0054
  21. Karnitz, L. M. and Abraham, R. T. (1995) Cytokine receptor signaling mechanisms. Curr. Opin. Immunol. 7, 320-326. https://doi.org/10.1016/0952-7915(95)80105-7
  22. Korherr, C., Hofmeister, R., Wesche, H. and Falk, W. (1997) A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur. J. Immunol. 27, 262-267. https://doi.org/10.1002/eji.1830270139
  23. Kyte, J. and Doolittle, R. F. (1982) A simple method for displaying the hydropathic charcter of a protein. J. Mol. Biol. 157, 105-132. https://doi.org/10.1016/0022-2836(82)90515-0
  24. Lenard, M. J. and Baltimore, D. (1989) $NK-{\kappa}B:$ A pleiotropic mediator of inducible and tissue specific gene control. Cell 58, 227-229. https://doi.org/10.1016/0092-8674(89)90833-7
  25. Libby, P., Warner, S. and Friedman, G. B. (1988) Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin. Invest. 81, 487-498. https://doi.org/10.1172/JCI113346
  26. Lin, C. C., Sun, C. C., Luo, S. F., Tsai, A. C., Chien, C. S., Hsiao, L. D., Lee, C. W., Hsieh, J. T. and Yang, C. M. (2004) Induction of cyclooxygenase-2 expression in human tracheal smooth muscle cells by interleukin-1beta: involvement of p42/p44 and p38 mitogen-activated protein kinases and nuclear factor-kappaB. J. Biomed. Sci. 11, 377-3790.
  27. Martin, M. U. and Falk, W. (1997) The interleukin-1 receptor complex and interleukin-1 signal transduction. Eur. Cytokine Netw. 8, 5-17.
  28. Martin, M. U. and Wesche H. (2002) Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta. 1592, 265-280. https://doi.org/10.1016/S0167-4889(02)00320-8
  29. Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennet, J. C., Ghanayem, B. I., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A. and Smithies, O. (1995) Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 583, 473-482.
  30. Nakae, S., Komiyama, Y., Yokoyama, H., Nambu, A., Umeda, M., Iwase, M., Homma, I., Sudo, K., Horai, R., Asano, M. and Iwakura, Y. (2003) IL-1 is required for allergen-specific Th2 cell activation and the development of airway hypersensitivity response. Int. Immunol. 15, 483-490. https://doi.org/10.1093/intimm/dxg054
  31. Nakae, S., Naruse-Nakajima, C., Sudo, K., Horai, R., Asano, M. and Iwakura, Y. (2001) IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity. Int. Immunol. 13, 1471-1478. https://doi.org/10.1093/intimm/13.12.1471
  32. Nishimura, R., Bowolaksono, A., Acosta, T. J., Murakami, S., Piotrowska, K., Skarzynski, D. J. and Okuda, K. (2004) Possible role of interleukin-1 in the regulation of bovine corpus luteum throughout the luteal phase. Biol. Reprod. 71, 1688-1693. https://doi.org/10.1095/biolreprod.104.032151
  33. Radeke, H. H., Schwinzer, B. and Resch, K. (1992) Activated Tlymphocytes induce growth inhibition and prostaglandin E2 release from syngeneic glomerular mesangial cells. Clin. Exp. Immunol. 90, 483-490. https://doi.org/10.1111/j.1365-2249.1992.tb05871.x
  34. Roesler, W. J., Vandenbark, G. R. and Hanson, R. W. (1988) Cyclic AMP and the induction of eukaryotic gene transcription. J. Biol. Chem. 263, 9063-9066.
  35. Schreuder, H., Tardif, C., Trump-Kallmeyer, S., Soffientini, A., Sarubbi, E., Akeson, A., Bowlin, T., Yanofsky, S. and Barrett, R. W. (1997) A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 386, 194-200. https://doi.org/10.1038/386194a0
  36. Schweizer, A., Feige, U., Fontana, A., Müller, K. and Dinarello, C. A. (1988) Interleukin-1 enhances pain reflexes: Mediation through increased prostaglandin E2 levels. Agents Actions 25, 246-251. https://doi.org/10.1007/BF01965025
  37. Sims, J. E., Gayle, M. A., Slack, J. L., Alderson, M. R., Bird, T. A., Giri, J. G., Colotta, F., Re, F., Mantovani, A., Shanebeck, K., Grabstein, K. H. and Dower, S. K. (1993) Interleukin-1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 90, 6155-6159.
  38. Singh, R., Guth, H. T., Konieczkowski, M. and Sedor, J. R. (1997) Cytosolic domain of the type I interleukin-1 receptor spontaneously recruits signaling molecules to activate a proinflammatory gene. J. Clin. Invest. 100, 419-428. https://doi.org/10.1172/JCI119549
  39. Singh, R., Wang, B., Shirvaikar, A., Khan, S., Kamat, S., Schelling, J. R., Konieczkowski, M. and Sedor, J. R. (1999) The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J. Clin. Invest. 103, 1561-1570. https://doi.org/10.1172/JCI5754
  40. Takii, T., Akahoshi, T., Kato, K., Hayashi, H., Marunouchi, T. and Onozaki, K. (1992) Interleukin-1 upregulates transcription of its own receptor in a human fibroblast cell line TIG-1. Role of endogenous $PGE_2$ and cAMP. Eur. J. Immunol. 22, 1221-1227. https://doi.org/10.1002/eji.1830220517
  41. Takii, T., Hayashi, H., Marunouchi, T. and Onozaki, K. (1994) Interleukin-1 downregulates type I interleukin-1 receptor mRNA expression in a human fibroblast cell line TIG-1 in the absence of prostaglandin E(2) synthesis. Lymphokine Cytokine Res. 13, 213-219.
  42. Vannier, E. and Dinarello, C. A. (1993) Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist. J. Clin. Invest. 92, 281-287. https://doi.org/10.1172/JCI116562
  43. Vannier, E. and Dinarello, C. A. (1994) Histamine enhances interleukin (IL)-1-induced IL-6 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. J. Biol. Chem. 269, 9952-9956.
  44. Vigers, G. P. A., Anderson, L. J., Caffes, P. and Brandhuber, B. J. (1997) Crystal structure of the type-1 interleukin-1 receptor complexed with interleukin-1b. Nature 386, 190-194. https://doi.org/10.1038/386190a0
  45. Volpe, F., Clatworthy, J., Kaptein, A., Maschera, B., Griffin, A. M. and Ray, K. (1997) The IL1 receptor accessory protein is responsible for the recruitment of the interleukin-1 receptor associated kinase to the IL1/IL1 receptor I complex. FEBS Lett. 419, 41-44. https://doi.org/10.1016/S0014-5793(97)01426-9
  46. Werman, A., Werman-Venkert, R., White, R., Lee, J. K., Werman, B., Krelin, Y., Voronov, E., Dinarello, C. A. and Apte R. N. (2004) The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc. Natl. Acad. Sci. USA 101, 2434-2439. https://doi.org/10.1073/pnas.0308705101
  47. Wesche, H., Korherr, C., Kracht, M., Falk, W., Resch, K. and Martin, M. U. (1997) The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stressactivated protein kinases (SAP kinases). J. Biol. Chem. 272, 7727-7731. https://doi.org/10.1074/jbc.272.12.7727
  48. Wesche, H., Neumann, D., Resch, K. and Martin, M. U. (1996) Co-expression of mRNA for type I and type II interleukin-1 receptors and the IL-1 receptor accessory protein correlates to IL-1 responsiveness. FEBS Lett. 391, 104-108. https://doi.org/10.1016/0014-5793(96)00713-2
  49. Yamada, H., Imoto, T., Fujita, K., Okazaki, K. and Motomura, M. (1981) Selective modification of aspartic acid-101 in lysozyme by carbodiimide reaction. Biochemistry 20, 4836-4842. https://doi.org/10.1021/bi00520a005
  50. Ye, K., Koch, K-C, Clark, B. D. and Dinarello, C. A. (1992) Interleukin-1 down regulates gene and surface expression of interleukin-1 receptor type I by destabilizing its mRNA whereas interleukin-2 increases its expression. Immunol. 75, 427-434.
  51. Yoon, D. Y. and Dinarello, C. A. (1998) Antibodies to domain II and III of the IL-1 receptor accessory protein inhibits $IL-1{\beta}$ activity but not binding: Regulation of IL-1 responses is via type I receptor, not the accessory protein. J. Immunol. 160, 3170-3179.
  52. Zhang, F., Lu, D., Wang, L., Chen, C. and Wu, N. (1998) Effects of IL-1 and TNF-alpha on the proliferation and cytosolic Ca2+ of lens epithelial cell in vitro. Zhonghua Yan Ke Za Zhi. 34, 106-108.

Cited by

  1. Interleukin-1 antagonists for diabetes vol.22, pp.8, 2013, https://doi.org/10.1517/13543784.2013.804060
  2. Nitric oxide involved in the IL-1β-induced inhibition of fructose intestinal transport vol.111, pp.5, 2010, https://doi.org/10.1002/jcb.22859